Semaglutide has emerged as a promising treatment for insulin resistance. This engineered glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to secrete more insulin and curbing glucagon https://miriamvpac469403.kylieblog.com/36277713/understanding-semaglutide-a-comprehensive-guide